BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Dutasteride

A 5-ALPHA-REDUCTASE INHIBITOR that is reported to inhibit both type-1 and type2 isoforms of the enzyme and is used to treat BENIGN PROSTATIC HYPERPLASIA.

298+ PubMed studies analyzed · 62 RCTs · Evidence Score: 55.7

Research Domains

Dutasteride has been studied across 16 research domains including 💪 Strength & Power, 🔬 Oncology, ✨ Skin & Hair, ♀♂ Sexual Health, 🧬 Hormones. The primary research focus is 💪 Strength & Power with 25% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dutasteride, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dimethyl
2 shared targets
Cefpodoxime
3 shared targets
Finasteride
4 shared targets
mefloquine
2 shared targets
Methylprednisolone
3 shared targets
alyssin
2 shared targets
Allylestrenol
2 shared targets
Metipranolol
2 shared targets
Triamcinolone
4 shared targets
onapristone
2 shared targets
Loading evidence profile...

This evidence profile for Dutasteride is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.